BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 38286882)

  • 61. Clinical outcomes of complete cytoreduction with concurrent liver resection followed by hyperthermic intraperitoneal chemotherapy for synchronous peritoneal and liver metastatic colorectal cancer.
    Jeon Y; Park EJ; Lim JH; Baik SH
    World J Surg Oncol; 2019 Dec; 17(1):214. PubMed ID: 31829188
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Stage IV Gastric Cancer with Positive Peritoneal Washing Cytology or Peritoneal Dissemination Was Successfully Treated with Gastrectomy and Hyperthermic Intraperitoneal Chemotherapy(HIPEC)Followed by Systemic Chemotherapy - A Report of Two Cases].
    Yamaguchi T; Murata S; Kaida S; Ohtake R; Takebayashi K; Yamamoto H; Miyake T; Akabori H; Sonoda H; Mori T; Shimizu T; Naka S; Moritani S; Kushima R; Tani M
    Gan To Kagaku Ryoho; 2016 Nov; 43(12):1954-1956. PubMed ID: 28133187
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Hyperthermic intraperitoneal chemotherapy].
    Leebmann H; Piso P
    Chirurg; 2019 Jul; 90(7):593-604. PubMed ID: 31190081
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Peritoneal carcinomatosis index and overall survival in patients taken to cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy.
    López-Basave HN; Morales-Vázquez F; Herrera-Gómez Á; Miranda-Devora G; Padilla-Rosciano AE; Castillo-Morales C; Paleta-Torres CA; Vázquez-Cortes E
    Cir Cir; 2023; 91(2):195-199. PubMed ID: 37084306
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Combined treatment with surgery and intraperitoneal hyperthermic perfusion (IPHP) for far-advanced gastrointestinal cancer with peritoneal seeding.
    Fujimoto S; Shrestha RD; Kobayashi K; Koike S; Kokubun M; Kiuchi S; Takahashi M; Konno C; Okui K
    Acta Med Austriaca; 1989; 16(3-4):76-80. PubMed ID: 2609917
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Repeated cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with recurrent peritoneal carcinomatosis.
    Vassos N; Förtsch T; Aladashvili A; Hohenberger W; Croner RS
    World J Surg Oncol; 2016 Feb; 14(1):42. PubMed ID: 26912149
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for managing peritoneal carcinomatosis from endometrial carcinoma: a single-center experience of 6 cases.
    Abu-Zaid A; Azzam AZ; AlOmar O; Salem H; Amin T; Al-Badawi IA
    Ann Saudi Med; 2014; 34(2):159-66. PubMed ID: 24894786
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Hyperthermic intraperitoneal chemotherapy (HIPEC) in combined treatment of locally advanced and intraperitonealy disseminated gastric cancer: A retrospective cooperative Central-Eastern European study.
    Yarema R; Mielko J; Fetsych T; Ohorchak M; Skorzewska M; Rawicz-Pruszyński K; Mashukov A; Maksimovsky V; Jastrzębski T; Polkowski W; Gyrya P; Kovalchuk Y; Safiyan V; Karelin I; Kopetskiy V; Kolesnik O; Kondratskiy Y; Paskonis M
    Cancer Med; 2019 Jun; 8(6):2877-2885. PubMed ID: 31033239
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Treatment of intraoperatively detected peritoneal carcinomatosis of colorectal origin with cytoreductive surgery and intraperitoneal chemotherapy.
    Canda AE; Arslan C; Terzi C; Sokmen S; Yavuzsen T; Ozkardesler S; Unlu M; Obuz F; Fuzun M
    World J Surg Oncol; 2018 Mar; 16(1):70. PubMed ID: 29587771
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Perioperative Management of Gastric Cancer Patients Treated With (Sub)Total Gastrectomy, Cytoreductive Surgery, and Hyperthermic Intraperitoneal Chemotherapy (HIPEC): Lessons Learned.
    Koemans WJ; Houwink A; van der Kaaij RT; Wassenaar ECE; Boerma D; Hahn C; Imhof O; Brandt MG; Ariëns MP; Veenhof AAFA; Hartemink KJ; van Sandick JW
    Ann Surg Oncol; 2021 Aug; 28(8):4647-4654. PubMed ID: 33389293
    [TBL] [Abstract][Full Text] [Related]  

  • 71. What made hyperthermic intraperitoneal chemotherapy an effective curative treatment for peritoneal surface malignancy: A 25-year experience with 1,125 procedures.
    Passot G; Vaudoyer D; Villeneuve L; Kepenekian V; Beaujard AC; Bakrin N; Cotte E; Gilly FN; Glehen O
    J Surg Oncol; 2016 Jun; 113(7):796-803. PubMed ID: 27110915
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Reply to "Peritoneal carcinomatosis in patients with gastric cancer and the role for surgical resection, cytoreductive surgery, and hyperthermic intraperitoneal chemotherapy".
    Graziosi L; Marino E; Donini A
    Am J Surg; 2014 Jul; 208(1):158-9. PubMed ID: 24530090
    [No Abstract]   [Full Text] [Related]  

  • 73. Effective therapy for peritoneal dissemination in gastric cancer.
    Yonemura Y; Bandou E; Kinoshita K; Kawamura T; Takahashi S; Endou Y; Sasaki T
    Surg Oncol Clin N Am; 2003 Jul; 12(3):635-48. PubMed ID: 14567022
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Impact of Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy in the Treatment of Gastric Cancer with Peritoneal Carcinomatosis: A Systematic Review and Meta-analysis.
    Martins M; Santos-Sousa H; Araújo F; Nogueiro J; Sousa-Pinto B
    Ann Surg Oncol; 2022 Nov; 29(12):7528-7537. PubMed ID: 35930109
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Safety and preliminary results of perioperative chemotherapy and hyperthermic intraperitoneal chemotherapy (HIPEC) for high-risk gastric cancer patients.
    Costa WL; Coimbra FJ; Ribeiro HS; Diniz AL; de Godoy AL; Begnami M; Silva MJ; Fanelli MF; Mello CA
    World J Surg Oncol; 2012 Sep; 10():195. PubMed ID: 22992263
    [TBL] [Abstract][Full Text] [Related]  

  • 76. CRS-HIPEC Prolongs Survival but is Not Curative for Patients with Peritoneal Carcinomatosis of Gastric Cancer.
    Boerner T; Graichen A; Jeiter T; Zemann F; Renner P; März L; Soeder Y; Schlitt HJ; Piso P; Dahlke MH
    Ann Surg Oncol; 2016 Nov; 23(12):3972-3977. PubMed ID: 27313067
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy with lobaplatin and docetaxel improves survival for patients with peritoneal carcinomatosis from abdominal and pelvic malignancies.
    Wu HT; Yang XJ; Huang CQ; Sun JH; Ji ZH; Peng KW; Zhang Q; Li Y
    World J Surg Oncol; 2016 Sep; 14(1):246. PubMed ID: 27633880
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Recent progress and future prospects of treatment for peritoneal metastasis in gastric cancer].
    Xu Y; Wang ZN
    Zhonghua Wei Chang Wai Ke Za Zhi; 2023 May; 26(5):414-418. PubMed ID: 37217347
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal peritoneal metastases: Where do we stand?
    Witmer HDD; Dhiman A; Turaga KK
    Cancer; 2023 Feb; 129(4):495-502. PubMed ID: 36527271
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Early Postoperative Chemotherapy After Complete Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy for Isolated Peritoneal Carcinomatosis of Colon Cancer: A Multicenter Study.
    Maillet M; Glehen O; Lambert J; Goere D; Pocard M; Msika S; Passot G; Elias D; Eveno C; Sabaté JM; Lourenco N; André T; Gornet JM;
    Ann Surg Oncol; 2016 Mar; 23(3):863-9. PubMed ID: 26480848
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.